Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection is a paper indexed in PICO Portal from OpenAlex.
How many citations does Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection have?
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection has 296 citations in the OpenAlex counts PICO Portal stores.
When was Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection published?
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection has 2012 year in the PICO Portal index.
What is the open-access status of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection?
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection has hybrid oa status in the PICO Portal index.
What is the DOI of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection?
The DOI for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection is on the source record.
What is the PMID of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection?
The PMID for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection is on the source record.
What is the OpenAlex record for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection?
The OpenAlex for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection is on the source record.